Flu News Items
State lifts limit on mercury preservative in swine-flu shots In preparation for swine-flu vaccinations next month, Washington's Health Department on Thursday temporarily suspended a rule that limits the amount of a mercury preservative in vaccines given to pregnant women and children under the age of 3.
Come on now, surely no one would believe that the U. S. Government would design a microchip implant to be implemented along with a “change” to a government run National Health Plan, would they? Well, believe it or not, that is exactly what is in the program that the Obama Administration is attempting to force on all of us!
Despite the ample evidence that vaccines often cause irreparable harm, there is even more compelling evidence that the pharmaceutical companies have found an even more harmful way to speed up the action of vaccines as well as make ever smaller doses do the work by “supercharging” them with a compound almost guaranteed to cause auto-immune problems lasting months, if not forever.
Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said Wednesday.
Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies.
As concerns grow of a possible flu pandemic onslaught this autumn, alert authorities worldwide have been stockpiling emergency supplies. Masks, gloves and anti-viral medications are on the list. And body bags.
We’re in a pandemic, but Hollywood reminds us that it could be a lot worse.
Pregnant women, health care workers and children six months and older should be placed at the front of the line for swine flu vaccinations this fall
Effectiveness to be determined in six to eight weeks, drug makers say
The world's first human trials of a swine flu vaccine have begun in Australia, drug company officials said Wednesday, with the aim of controlling the virus that has so far killed more than 700 worldwide.
Vaxine and CSL have both started injecting volunteers this week, but it will be at least six weeks before the initial results are known.
The federal government is committing more than $800 million to buy more of the two key ingredients to make the H1N1 swine flu vaccine, according to the Department of Health and Human Services.
The medical establishment in Britain, the nation hardest hit by swine flu outside North America, is scrambling to roll out a large-scale vaccination program in an effort to protect its population against a virus that threatens to spread rapidly here in coming weeks.